{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:58:51Z","timestamp":1792022331152,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jchf.2017.09.015","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T17:40:06Z","timestamp":1519926006000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":399,"title":["Post-Myocardial Infarction Heart Failure"],"prefix":"10.1016","volume":"6","author":[{"given":"M. Cecilia","family":"Bahit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajar","family":"Kochar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2017.09.015_bib1","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0002-9343(02)01185-3","article-title":"Heart failure after myocardial infarction: a review","volume":"113","author":"Hellermann","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib3","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/01.CIR.91.6.1659","article-title":"Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction","volume":"91","author":"Lee","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.09.015_bib4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0002-8703(99)70080-3","article-title":"Clinical predictors of heart failure in patients with first acute myocardial infarction","volume":"138","author":"Ali","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2017.09.015_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.09.015_bib6","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.CIR.0000017861.00991.2F","article-title":"Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction","volume":"105","author":"Spencer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.09.015_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCHEARTFAILURE.112.968180","article-title":"Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry","volume":"5","author":"Shah","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2017.09.015_bib8","article-title":"Heart failure complicating acute myocardial infarction; burden and timing of occurrence: a nation-wide analysis including 86 771 patients from the Cardiovascular Disease in Norway (CVDNOR) Project","volume":"5","author":"Sulo","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2017.09.015_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.amjcard.2006.03.023","article-title":"Prognostic significance of admission heart failure in patients with non\u2013ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries)","volume":"98","author":"Segev","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2017.09.015_bib10","first-page":"223","article-title":"Heart failure complicating non\u2013ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes","volume":"1","author":"Bahit","year":"2013","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2017.09.015_bib11","first-page":"326","article-title":"Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry","volume":"65","author":"Juilliere","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jchf.2017.09.015_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.09.015_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta-blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jchf.2017.09.015_bib14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0735-1097(01)01682-5","article-title":"AHA\/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology","volume":"38","author":"Smith","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.09.015_bib15","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0195-668X(03)00347-6","article-title":"European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"24","author":"De Backer","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.09.015_bib16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","article-title":"Expert consensus document on beta-adrenergic receptor blockers","volume":"25","author":"L\u00f3pez-Send\u00f3","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.09.015_bib17","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jchf.2017.09.015_bib18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.09.015_bib19","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.09.015_bib20","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.09.015_bib21","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.09.015_bib22","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","article-title":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.09.015_bib23","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.09.015_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib25","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.09.015_bib26","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A\u00a0clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"Kober","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan captopril on mortality morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.09.015_bib30","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/eurjhf\/hfp136","article-title":"Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial","volume":"11","author":"Adamopoulos","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2017.09.015_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0002-9343(93)90058-W","article-title":"Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT study group","volume":"94","author":"Leor","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/euhj.2000.2312","article-title":"Trends in cardiogenic shock: report from the SHOCK study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?","volume":"22","author":"Carnendran","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.09.015_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcin.2015.10.039","article-title":"Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry","volume":"9","author":"Wayangankar","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jchf.2017.09.015_bib35","doi-asserted-by":"crossref","unstructured":"van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 2017;136:e232-68.","DOI":"10.1161\/CIR.0000000000000525"},{"key":"10.1016\/j.jchf.2017.09.015_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib37","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2017.09.015_bib38","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib39","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.09.015_bib40","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Neumann FJ, et al. \u201cIntra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.\u201d Lancet 2013;382:1638-45.","DOI":"10.1016\/S0140-6736(13)61783-3"},{"key":"10.1016\/j.jchf.2017.09.015_bib41","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.2011.1280","article-title":"Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial","volume":"306","author":"Patel","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2017.09.015_bib42","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2014.07.958","article-title":"National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis","volume":"64","author":"Stretch","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.09.015_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jacc.2016.10.026","article-title":"\u201cImpella CP Versus Intra-Aortic Balloon Pump in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The IMPRESS trial.\u201d","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.09.015_bib44","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.09.015_bib45","unstructured":"Prospective ARNI vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI (PARADISE-MI). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02924727. Accessed May 31, 2017."},{"key":"10.1016\/j.jchf.2017.09.015_bib46","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.09.015_bib47","unstructured":"Impact of EMpagliflozin on Cardiac Function and Bimarkers of Heart Failure in Patients With Acute Myocardial Infarction (EMMY). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03087773?term=Heart+Failure%2C+Myocardial+Infarction&rank=18. Accessed May 31, 2017."},{"key":"10.1016\/j.jchf.2017.09.015_bib48","unstructured":"Door to Unloading With IMPELLA CP System in Acute Myocardial Infarction (DTU). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03000270. Accessed May 31, 2017."}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917306789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917306789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T18:52:52Z","timestamp":1658256772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177917306789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213177917306789"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2017.09.015","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Myocardial Infarction Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2017.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}